Objectives: This is an advidory board of brazilian KOLs about temple treatments with fillers aiming safety and expected outcomes. (participants: Gladstone faria, Daniel boro, Andre braz, Eliandre palermo, Bruna Bravo, Luiz Avelar, Daniel coimbra, Aneta vassiliadis, Alessandra haddad, Mariana Muniz, Ada Trindade, Ricardo Boggio)
Introduction: The temporal region is emblematic and challenging due to its structural and volumetric changes during aging, which significantly affect facial aesthetics. Despite the importance of addressing temporal aging, many injectors hesitate due to the region's anatomical complexity and risk of complications. This consensus aimed to provide expert guidance on the safest and most effective treatment strategies for the temple.
Materials / method: Twelve Brazilian dermatologists and plastic surgeons with expertise in cosmiatry participated in a survey of 54 objective and one open-ended question to identify best practices. The results were analyzed for consensus, with agreement categorized as a simple majority (50-75%), consensus (>75%), or strong consensus (>95%)
Results: Participants agreed that volumization (100%), lifting (90%), and restructuring (82%) are essential for temporal rejuvenation. Hyaluronic acid (HA) was the preferred product for volumization and structuring, with the subcutaneous plane identified as the best option for both. There was no consensus on the product for lifting, though 45.5% favored poly-L-lactic acid (PLLA). Biostimulants such as PLLA and calcium hydroxyapatite (CaHA) were commonly used, with specific dilution strategies. Complications reported included hematomas and nodules, particularly with HA and PLLA. Conclusion: The consensu
Conclusion: The findings highlight the need for expert-driven approaches to reduce the risk of complications and optimize patient outcomes in this sensitive region.
Disclosures
Did you receive any funding to support your research for this TOPIC?
No
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work was not supported by any direct or non direct funding. It is under the author's own responsability